Market Moves
ONWARD Medical Raises €40.6m to Scale ARC Therapy Rollout and Fund Implantable Pipeline
The Eindhoven-listed neurotech priced a private placement at €3.00 per share, led by EQT Life Sciences, to expand ARC-EX commercial operations and advance ARC-IM through regulatory work. Cash runway extends into Q1 2028.